ARL6IP5 and neoplasm: Dysregulation of JWA has been found to be involved in tumor progression through multiple mechanisms, including tumor angiogenesis and metastasis, chemotherapy resistance, apoptosis, and involvement in tumor metabolism [21,22,23,24,25].